By Zhian Chen and Di Yu
PMID: 35355007
Context-dependent functions of pattern recognition receptors in cancer.
Man SM, Jenkins BJ.
Nat Rev Cancer. 2022 Jul;22(7):397-413. doi: 10.1038/s41568-022-00462-5. Epub 2022 Mar 30.PMID: 35355007 Review.
PMID: 35790881
IL-17 and IL-17-producing cells in protection versus pathology.
Mills KHG.
Nat Rev Immunol. 2022 Jul 5:1-17. doi: 10.1038/s41577-022-00746-9. Online ahead of print.PMID: 35790881 Free PMC article. Review.
PMID: 35650271
Role of thymic stromal lymphopoietin in allergy and beyond.
Ebina-Shibuya R, Leonard WJ.
Nat Rev Immunol. 2022 Jun 1:1-14. doi: 10.1038/s41577-022-00735-y. Online ahead of print.PMID: 35650271 Free PMC article. Review.
PMID: 35879417
Mitochondrial control of inflammation.
Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L.
Nat Rev Immunol. 2022 Jul 25:1-15. doi: 10.1038/s41577-022-00760-x. Online ahead of print.PMID: 35879417 Free PMC article. Review.
PMID: 35217787
Engineering IL-2 for immunotherapy of autoimmunity and cancer.
Hernandez R, Põder J, LaPorte KM, Malek TR.
Nat Rev Immunol. 2022 Feb 25. doi: 10.1038/s41577-022-00680-w. Online ahead of print.PMID: 35217787 Review.
PMID: 35354980
Heterogeneity of type 2 innate lymphoid cells.
Spits H, Mjösberg J.
Nat Rev Immunol. 2022 Mar 30:1-12. doi: 10.1038/s41577-022-00704-5. Online ahead of print.PMID: 35354980 Free PMC article. Review.
PMID: 35322259
The role of PI3Kγ in the immune system: new insights and translational implications.
Lanahan SM, Wymann MP, Lucas CL.
Nat Rev Immunol. 2022 Mar 23. doi: 10.1038/s41577-022-00701-8. Online ahead of print.PMID: 35322259 Review.
PMID: 35246670
Inflammation and immune dysfunction in Parkinson disease.
Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V.
Nat Rev Immunol. 2022 Mar 4:1-17. doi: 10.1038/s41577-022-00684-6. Online ahead of print.PMID: 35246670 Free PMC article. Review.
PMID: 35277664
The link between circulating follicular helper T cells and autoimmunity.
Walker LSK.
Nat Rev Immunol. 2022 Mar 11:1-9. doi: 10.1038/s41577-022-00693-5. Online ahead of print.PMID: 35277664 Free PMC article. Review.
PMID: 35729334
IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.
Broderick L, Hoffman HM.
Nat Rev Rheumatol. 2022 Aug;18(8):448-463. doi: 10.1038/s41584-022-00797-1. Epub 2022 Jun 21.PMID: 35729334 Free PMC article. Review.
PMID: 35817844
Targeting TFH cells in human diseases and vaccination: rationale and practice.
Yu D, Walker LSK, Liu Z, Linterman MA, Li Z.
Nat Immunol. 2022 Jul 11. doi: 10.1038/s41590-022-01253-8. Online ahead of print.PMID: 35817844 Review.
PMID: 35241833
Huang AC, Zappasodi R.
Nat Immunol. 2022 May;23(5):660-670. doi: 10.1038/s41590-022-01141-1. Epub 2022 Mar 3.PMID: 35241833 Free PMC article. Review.
PMID: 35691784
Biogenesis and engineering of interleukin 12 family cytokines.
Hildenbrand K, Aschenbrenner I, Franke FC, Devergne O, Feige MJ.
Trends Biochem Sci. 2022 Jun 9:S0968-0004(22)00138-4. doi: 10.1016/j.tibs.2022.05.005. Online ahead of print.PMID: 35691784 Review.
PMID: 35277286
Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease.
Nielsen OH, Boye TL, Chakravarti D, Gubatan J.
Trends Pharmacol Sci. 2022 May;43(5):424-436. doi: 10.1016/j.tips.2022.02.008. Epub 2022 Mar 8.PMID: 35277286 Review.
PMID: 35570161
IL-33-ILC2 axis in the female reproductive tract.
Miller JE, Koti M, Tayade C.
Trends Mol Med. 2022 Jul;28(7):569-582. doi: 10.1016/j.molmed.2022.04.006. Epub 2022 May 12.PMID: 35570161 Review.
PMID: 35492880
Harnessing the chemokine system to home CAR-T cells into solid tumors.
Foeng J, Comerford I, McColl SR.
Cell Rep Med. 2022 Feb 28;3(3):100543. doi: 10.1016/j.xcrm.2022.100543. eCollection 2022 Mar 15.PMID: 35492880 Free PMC article. Review.
PMID: 35753845
Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.
Squillace S, Salvemini D.
Trends Pharmacol Sci. 2022 Jun 23:S0165-6147(22)00127-4. doi: 10.1016/j.tips.2022.05.004. Online ahead of print.PMID: 35753845 Review.
PMID: 35501268
Utilizing chemokines in cancer immunotherapy.
Märkl F, Huynh D, Endres S, Kobold S.
Trends Cancer. 2022 Aug;8(8):670-682. doi: 10.1016/j.trecan.2022.04.001. Epub 2022 Apr 29.PMID: 35501268 Review.
PMID: 35513901
NLRP3 and pyroptosis blockers for treating inflammatory diseases.
Coll RC, Schroder K, Pelegrín P.
Trends Pharmacol Sci. 2022 Aug;43(8):653-668. doi: 10.1016/j.tips.2022.04.003. Epub 2022 May 3.PMID: 35513901 Free article. Review.
PMID: 35624009
Therapeutic potential of interleukin-2 in autoimmune diseases.
Yuan Y, Kolios AGA, Liu Y, Zhang B, Li H, Tsokos GC, Zhang X.
Trends Mol Med. 2022 Jul;28(7):596-612. doi: 10.1016/j.molmed.2022.04.010. Epub 2022 May 24.PMID: 35624009 Review.
PMID: 35302863
Transforming growth factor-β1 in regulatory T cell biology.
Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z.
Sci Immunol. 2022 Mar 18;7(69):eabi4613. doi: 10.1126/sciimmunol.abi4613. Epub 2022 Mar 18.PMID: 35302863 Review.
PMID: 35306673
Ding J, Maxwell A, Adzibolosu N, Hu A, You Y, Liao A, Mor G.
Immunol Rev. 2022 Jul;308(1):9-24. doi: 10.1111/imr.13077. Epub 2022 Mar 20.PMID: 35306673 Review.
PMID: 35656941
Unique aspects of IFN-γ/STAT1 signaling in neurons.
Clark DN, Begg LR, Filiano AJ.
Immunol Rev. 2022 Jun 3. doi: 10.1111/imr.13092. Online ahead of print.PMID: 35656941 Review.
PMID: 35039323
Cutaneous signs and mechanisms of inflammasomopathies.
Borst C, Symmank D, Drach M, Weninger W.
Ann Rheum Dis. 2022 Apr;81(4):454-465. doi: 10.1136/annrheumdis-2021-220977. Epub 2022 Jan 17.PMID: 35039323 Review.
PMID: 35732818
Feng Z, Sun R, Cong Y, Liu Z.
Mucosal Immunol. 2022 Jun 22. doi: 10.1038/s41385-022-00538-3. Online ahead of print.PMID: 35732818 Review.
PMID: 35902046
Hu Y, Chen B, Yang F, Su Y, Yang D, Yao Y, Wang S, Wu Y, Tao L, Xu T.
Autoimmun Rev. 2022 Jul 25;21(9):103155. doi: 10.1016/j.autrev.2022.103155. Online ahead of print.PMID: 35902046 Review.
PMID: 35595051
Significance of IL-7 and IL-7R in RA and autoimmunity.
Meyer A, Parmar PJ, Shahrara S.
Autoimmun Rev. 2022 Jul;21(7):103120. doi: 10.1016/j.autrev.2022.103120. Epub 2022 May 17.PMID: 35595051 Review.
COVID-19 special collection
PMID: 35788185
Considering innate immune responses in SARS-CoV-2 infection and COVID-19.
Diamond MS, Lambris JD, Ting JP, Tsang JS.
Nat Rev Immunol. 2022 Aug;22(8):465-470. doi: 10.1038/s41577-022-00744-x. Epub 2022 Jul 4.PMID: 35788185 Free PMC article.
PMID: 35304596
SARS-CoV-2 infection and COVID-19 vaccination in pregnancy.
Male V.
Nat Rev Immunol. 2022 May;22(5):277-282. doi: 10.1038/s41577-022-00703-6. Epub 2022 Mar 18.PMID: 35304596 Free PMC article. Review.
PMID: 35484322
Kent SJ, Khoury DS, Reynaldi A, Juno JA, Wheatley AK, Stadler E, John Wherry E, Triccas J, Sasson SC, Cromer D, Davenport MP.
Nat Rev Immunol. 2022 Jun;22(6):387-397. doi: 10.1038/s41577-022-00716-1. Epub 2022 Apr 28.PMID: 35484322 Free PMC article. Review.
PMID: 35277694
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.
Fendler A, de Vries EGE, GeurtsvanKessel CH, Haanen JB, Wörmann B, Turajlic S, von Lilienfeld-Toal M.
Nat Rev Clin Oncol. 2022 Jun;19(6):385-401. doi: 10.1038/s41571-022-00610-8. Epub 2022 Mar 11.PMID: 35277694 Free PMC article. Review.
PMID: 35354968
Lamers MM, Haagmans BL.
Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.PMID: 35354968 Review.
PMID: 35637104
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases.
Bhattacharya D.
Immunity. 2022 Jun 14;55(6):945-964. doi: 10.1016/j.immuni.2022.05.004. Epub 2022 May 10.PMID: 35637104 Free PMC article. Review.
PMID: 35277325
COVID-19 in pregnancy: implications for fetal brain development.
Shook LL, Sullivan EL, Lo JO, Perlis RH, Edlow AG.
Trends Mol Med. 2022 Apr;28(4):319-330. doi: 10.1016/j.molmed.2022.02.004. Epub 2022 Feb 14.PMID: 35277325 Free PMC article. Review.
PMID: 35810128
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.
Doty RL.
Trends Mol Med. 2022 Jun 20:S1471-4914(22)00160-5. doi: 10.1016/j.molmed.2022.06.005. Online ahead of print.PMID: 35810128 Free PMC article. Review.
PMID: 35697684
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.
Li X, Zhang Z, Wang Z, Gutiérrez-Castrellón P, Shi H.
Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.PMID: 35697684 Free PMC article. Review.
PMID: 35775361
Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection.
Chiale C, Greene TT, Zuniga EI.
Immunol Rev. 2022 Aug;309(1):12-24. doi: 10.1111/imr.13113. Epub 2022 Jul 1.PMID: 35775361 Free PMC article. Review.
PMID: 35597182
Trained immunity: implications for vaccination.
Geckin B, Konstantin Föhse F, Domínguez-Andrés J, Netea MG.
Curr Opin Immunol. 2022 Aug;77:102190. doi: 10.1016/j.coi.2022.102190. Epub 2022 May 18.PMID: 35597182 Free article. Review.
